Parotid Gland Cancer: Causes, Symptoms, Diagnosis, Treatment and Prevention

Parotid Gland Cancer: Causes, Symptoms, Diagnosis, Treatment & Outlook

Parotid gland cancer is a type of salivary gland malignancy that originates in the parotid glands, the largest of the three major salivary glands located on each side of the face, just in front of the ears. Although salivary gland cancers are relatively rare—representing less than 5% of all head and neck cancers—the parotid gland is the most common site where these tumors arise. Most tumors in this gland are benign, but a significant minority are malignant and require prompt evaluation and treatment.

This article provides a clear and complete understanding of parotid gland cancer, including its causes, symptoms, diagnostic approach, treatment options, and overall prognosis.

~Introduction

The parotid glands produce saliva to help with chewing, digestion, lubrication, and maintaining oral health. Tumors can arise from the epithelial cells, ductal cells, myoepithelial cells, and other specialized salivary gland tissues.

Although the majority of parotid tumors (about 70–80%) are benign—such as pleomorphic adenoma—malignant tumors can be aggressive and may spread to nearby structures, including the facial nerve, lymph nodes, and distant organs like the lungs.

~Anatomy of the Parotid Gland

Understanding the anatomy helps clinicians assess symptoms and treatment options:

• Each parotid gland contains two lobes: superficial and deep, separated by the facial nerve.

• The gland drains saliva into the mouth through the Stensen’s duct, opening near the upper molars.

• Due to the proximity of the facial nerve, tumors in this gland can affect facial movement.

~Types of Parotid Gland Tumors

Benign Tumors

These include:

• Pleomorphic adenoma (most common)

• Warthin’s tumor

• Oncocytoma

Though benign, pleomorphic adenomas can transform into malignancy if untreated.

Malignant Tumors

Common cancer types include:

• Mucoepidermoid carcinoma — most common malignant type

• Adenoid cystic carcinoma

• Acinic cell carcinoma

• Salivary duct carcinoma

• Adenocarcinoma

• Squamous cell carcinoma (rare as primary; often metastatic)

Each type varies in aggressiveness and response to therapy.

~Causes and Risk Factors

The exact cause of parotid gland cancer is not fully understood, but several risk factors have been identified:

1. Prior Radiation Exposure

• Radiation therapy to the head/neck area increases risk.

• Exposure to nuclear or industrial radiation is also linked.

2. Viral Infections

Certain viruses are associated with higher risk:

• Epstein–Barr virus (EBV)

• Human papillomavirus (HPV)

• HIV (increases susceptibility)

3. Age and Gender

• More common in adults over 50 years.

• Some malignant types are more frequent in men.

4. Occupational Exposure

Jobs involving:

• Rubber manufacturing

• Nickel compounds

• Asbestos

• Silica dust

may increase cancer risk.

5. Genetic Factors

Family history and inherited mutations may contribute, although rare.

6. Smoking

Associated with Warthin’s tumor and, to a lesser extent, some malignant salivary tumors.

~Symptoms of Parotid Gland Cancer

Symptoms can vary depending on tumor growth, aggressiveness, and involvement of nearby structures.

1. Common Symptoms

• Painless lump in front of or below the ear

• Swelling on one side of the face

• Firm or fixed mass (malignant tumors tend to be more fixed)

2. Facial Nerve Involvement

A key indicator of malignancy:

• Facial weakness or paralysis

• Drooping of one side of the face

• Difficulty closing the eye

• Loss of facial expressions

3. Pain and Discomfort

• Persistent pain in the ear, jaw, or neck

• Tingling sensation in the face

4. Other Symptoms

• Ulceration of the skin over the tumor

• Swallowing difficulty (rare)

• Enlargement of neck lymph nodes

Any persistent parotid lump should be evaluated by an ENT specialist or head & neck oncologist.

~Diagnosis

1. Physical Examination

A thorough head and neck exam assesses:

• Size and consistency of the mass

• Mobility

• Skin involvement

• Facial nerve function

• Lymph nodes

2. Imaging Tests

These confirm tumor location and extent:

Ultrasound

Useful for initial evaluation and guiding biopsy.

CT Scan

Shows bony involvement and overall structure.

MRI

Excellent for evaluating:

• Soft tissue spread

• Facial nerve involvement

• Deep lobe tumors

PET-CT

Used for high-grade cancers to detect metastasis.

3. Biopsy

Fine Needle Aspiration Cytology (FNAC) is standard for most parotid lumps.

In some cases, core biopsy may be performed for more details.

4. Histopathology

Definitive diagnosis and grading depend on microscopic examination after tumor removal.

~Staging of Parotid Gland Cancer

Staging follows the TNM system:

• T = tumor size and spread within the gland

• N = lymph node involvement

• M = distant metastasis

Stages range from I (least advanced) to IV (most advanced).

~Treatment Options

Treatment depends on tumor type, stage, grade, and involvement of the facial nerve or lymph nodes.

1. Surgery — Main Treatment

Superficial Parotidectomy

Removal of the superficial lobe; used for many benign and small malignant tumors.

Total Parotidectomy

Removal of both superficial and deep lobes.

Radical Parotidectomy

Removal of the gland along with the facial nerve if the tumor has invaded it.

Neck Dissection

If lymph nodes are involved or if the cancer is high-grade.

Reconstructive Surgery

To restore facial function and appearance, including nerve grafts and flap reconstruction.

2. Radiation Therapy

Indicated for:

• High-grade tumors

• Close or positive surgical margins

• Facial nerve involvement

• Lymph node spread

• Advanced cancers

IMRT (Intensity-Modulated Radiotherapy) helps protect surrounding tissues.

3. Chemotherapy

Used less often than in other head & neck cancers, but may be used in:

• Advanced, unresectable tumors

• Recurrent disease

• Palliative care

Common drugs include:

• Cisplatin

• Carboplatin

• 5-FU

• Taxanes

4. Targeted Therapy & Immunotherapy

Used for specific advanced cancer types:

• Trastuzumab for HER2-positive tumors

• Nivolumab / Pembrolizumab for certain recurrent or metastatic cases

• Androgen deprivation therapy for salivary duct carcinoma

These treatments are expanding with ongoing research.

~Complications

Surgical Complications

• Facial nerve palsy

• Frey’s syndrome (sweating on the cheek while eating)

• Ear numbness

• Salivary fistula

• Visible scarring

Radiation Side Effects

• Dry mouth

• Skin changes

• Stiffness of the jaw

• Taste alteration

Psychological & Functional Effects

Changes in appearance and facial movement may affect emotional well-being.

~Prognosis

Prognosis depends on:

• Tumor type and grade

• Stage at diagnosis

• Facial nerve involvement

• Lymph node metastasis

• Completeness of tumor removal

General Outcomes

• Low-grade tumors: Excellent prognosis with 10-year survival > 90%

• High-grade tumors: More aggressive with higher recurrence rates

• Facial nerve involvement: Associated with poorer outcomes

Early diagnosis is crucial.

~Prevention

While parotid gland cancers are not strongly linked to lifestyle factors, some preventive steps include:

• Avoid unnecessary radiation exposure

• Quit smoking

• Maintain good oral and dental hygiene

• Manage viral infections with medical care

• Use protective equipment in high-risk occupations

Regular check-ups for persistent lumps or symptoms are essential.

~Living with Parotid Gland Cancer

Recovery often requires:

• Physical therapy to regain facial movement

• Speech therapy if nerves were affected

• Nutritional support during treatment

• Psychological counseling

• Regular follow-ups to detect recurrence

Support groups and rehabilitation specialists play a major role in long-term recovery.

~Conclusion

Parotid gland cancer is a rare but significant condition that requires timely diagnosis and tailored treatment. Because the tumor is located near the facial nerve and other critical structures, early recognition and management are essential to avoid complications and improve survival outcomes.

Modern surgical techniques, radiation therapy, targeted therapy, and immunotherapy have greatly improved the outlook for many patients. Awareness, routine evaluations for persistent lumps, and access to specialized head & neck oncologists can make a substantial difference in outcomes.